Eisner Mark (CIK 1834161) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-26). Recent activity: Sell VIR (1,616 shares), Sell VIR (1,889 shares), Buy VIR (55,000 shares), Sell VIR (2,089 shares), Sell VIR (6,796 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-26 | Vir Biotechnology, Inc. (VIR) | EVP and Chief Medical Officer | Sell | 1,616 | $15,400 |
| 2026-02-26 | Vir Biotechnology, Inc. (VIR) | EVP and Chief Medical Officer | Sell | 1,889 | $18,550 |
| 2026-02-24 | Vir Biotechnology, Inc. (VIR) | EVP and Chief Medical Officer | Buy | 55,000 | $0 |
| 2026-02-24 | Vir Biotechnology, Inc. (VIR) | EVP and Chief Medical Officer | Sell | 2,089 | $15,563 |
| 2025-07-17 | Vir Biotechnology, Inc. (VIR) | EVP and Chief Medical Officer | Sell | 6,796 | $37,174 |
| 2025-07-17 | Vir Biotechnology, Inc. (VIR) | EVP and Chief Medical Officer | Sell | 3,586 | $19,615 |
| 2025-02-25 | Vir Biotechnology, Inc. (VIR) | EVP and Chief Medical Officer | Buy | 40,000 | $0 |
Source: SEC Form 4 filings · as of 2026-02-26